These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19114584)

  • 1. CATIE findings revisited.
    Davis JM; Leucht S; Glick ID
    Psychiatr Serv; 2009 Jan; 60(1):125-6. PubMed ID: 19114584
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipsychotics and metabolics in the post-CATIE era.
    Meyer JM
    Curr Top Behav Neurosci; 2010; 4():23-42. PubMed ID: 21312396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should the CATIE study be a wake-up call?
    Ragins M
    Psychiatr Serv; 2005 Dec; 56(12):1489. PubMed ID: 16339608
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness measures, methods, and policy implications from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for schizophrenia.
    Rosenheck RA; Lieberman JA
    J Clin Psychiatry; 2007 Feb; 68(2):e05. PubMed ID: 17335313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CATIE: welcome to the real world].
    Alvarez E; Bernardo M; Roca M
    Actas Esp Psiquiatr; 2006; 34(4):213-5. PubMed ID: 16823680
    [No Abstract]   [Full Text] [Related]  

  • 6. The CATIE schizophrenia effectiveness trial.
    Delisi LE; Nasrallah HA
    Schizophr Res; 2005 Dec; 80(1):v-vi. PubMed ID: 16291292
    [No Abstract]   [Full Text] [Related]  

  • 7. The CATIE study and its implications for antipsychotic drug use.
    Janicak PG
    Essent Psychopharmacol; 2006; 7(1):53-63. PubMed ID: 16989293
    [No Abstract]   [Full Text] [Related]  

  • 8. Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond.
    Nasrallah HA
    J Clin Psychiatry; 2007; 68 Suppl 1():3-4. PubMed ID: 17286521
    [No Abstract]   [Full Text] [Related]  

  • 9. Revisiting the CATIE schizophrenia study. Although questions remain, some clinical guidance has emerged.
    Harv Ment Health Lett; 2008 Jul; 25(1):1-3. PubMed ID: 18777649
    [No Abstract]   [Full Text] [Related]  

  • 10. Discontinuing and switching antipsychotic medications: understanding the CATIE schizophrenia trial.
    Weiden PJ
    J Clin Psychiatry; 2007; 68 Suppl 1():12-9. PubMed ID: 17286523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of CATIE for mental health services researchers.
    Covell NH; Finnerty MT; Essock SM
    Psychiatr Serv; 2008 May; 59(5):526-9. PubMed ID: 18451010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to the CATIE special section.
    Swartz MS
    Psychiatr Serv; 2008 May; 59(5):497-9. PubMed ID: 18451004
    [No Abstract]   [Full Text] [Related]  

  • 13. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
    Heinrichs RW
    Arch Gen Psychiatry; 2007 Jun; 64(6):631-2. PubMed ID: 17548745
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state.
    Berkowitz RL; Patel U; Ni Q; Parks JJ; Docherty JP
    J Clin Psychiatry; 2012 Apr; 73(4):498-503. PubMed ID: 22226332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE).
    Lieberman JA
    Arch Gen Psychiatry; 2006 Oct; 63(10):1069-72. PubMed ID: 17015808
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale.
    Keefe RS; Mohs RC; Bilder RM; Harvey PD; Green MF; Meltzer HY; Gold JM; Sano M
    Schizophr Bull; 2003; 29(1):45-55. PubMed ID: 12908660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CATIE study.
    Basil B; Mathews M; Adetunji B; Budur K
    Am J Psychiatry; 2006 Mar; 163(3):555; author reply 555-6. PubMed ID: 16513895
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.
    Swartz MS; Perkins DO; Stroup TS; McEvoy JP; Nieri JM; Haak DC
    Schizophr Bull; 2003; 29(1):33-43. PubMed ID: 12908659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE).
    Kane JM
    J Clin Psychiatry; 2006 May; 67(5):831-2. PubMed ID: 16841634
    [No Abstract]   [Full Text] [Related]  

  • 20. Selecting antipsychotics in schizophrenia: lessons from CATIE.
    Haddad P; Dursun SM
    J Psychopharmacol; 2006 May; 20(3):332-4. PubMed ID: 16574710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.